Proteome Sciences' 2011 Revenues Climb Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – Proteome Sciences preliminarily reported Tuesday that its revenues more than doubled year over year for full-year 2011.

For the year ended Dec. 31, 2011, the UK company recorded revenues of £1.0 million ($1.6 million), up from £450,088 for full-year 2010. The 2010 figure excludes the exceptional £9.5 million in income from the Sanofi-Aventis warranty claim settlement, Proteome Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: sequencing technique to uncover plant disease-resistance genes, and more.

In a Science Translational Medicine opinion piece, a Merck executive suggests that universities offer money-back guarantees on their research.

NantKwest's Patrick Soon-Shiong received some $148 million in compensation in 2015.

With sequencing moving toward applications, Illumina CEO Francis deSouza says his company has even more to offer, Fast Company reports.